INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Three-Dimensional Collagen Type I Matrix Up-Regulates Nuclear Isoforms of the Microtubule Associated Protein Tau Implicated in Resistance to Paclitaxel Therapy in Ovarian Carcinoma

Show simple item record

Bookmark or cite this item: http://hdl.handle.net/10027/20639

Files in this item

File Description Format
PDF Three-Dimentional Collagen.pdf (5MB) Main Article PDF
Title: Three-Dimensional Collagen Type I Matrix Up-Regulates Nuclear Isoforms of the Microtubule Associated Protein Tau Implicated in Resistance to Paclitaxel Therapy in Ovarian Carcinoma
Author(s): Gurler, H.; Yu, Y.; Choi, J.; Kajdacsy-Balla, A.A.; Barbolina, M.V.
Subject(s): serous epithelial ovarian carcinoma microtubule associated protein tau paclitaxel three-dimensional collagen matrix
Abstract: Epithelial ovarian carcinoma is the deadliest gynecologic malignancy. One reason underlying treatment failure is resistance to paclitaxel. Expression of the microtubule associated protein tau has recently been proposed as a predictor of response to paclitaxel in ovarian carcinoma patients. Expression of tau was probed using immunohistochemistry in 312 specimens of primary, and 40 specimens of metastatic, ovarian carcinoma. Serous epithelial ovarian carcinoma cell line models were used to determine the expression of tau by Western blot and immunofluorescence staining. Subcellular fractionation and Western blot were employed to examine nuclear and cytoplasmic localization of tau. Gene silencing and clonogenic assays were used to evaluate paclitaxel response. Tau was expressed in 44% of all tested cases. Among the primary serous epithelial ovarian carcinoma cases, 46% were tau-positive. Among the metastatic serous epithelial ovarian carcinomas, 63% were tau-positive. Cell culture experiments demonstrated that tau was expressed in multiple isoforms. Three-dimensional collagen I matrix culture conditions resulted in up-regulation of tau protein. Silencing of tau with specific siRNAs in a combination with three-dimensional culture conditions led to a significant decrease of the clonogenic ability of cells treated with paclitaxel. The data suggest that reduction of tau expression may sensitize ovarian carcinoma to the paclitaxel treatment.
Issue Date: 2015-02-04
Publisher: MDPI
Citation Info: Gurler, Hilal, et al. "Three-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma." International journal of molecular sciences 16.2 (2015): 3419-3433. DOI: 10.3390/ijms16023419.
Type: Article
Description: This is a copy of an article published in the © 2015 MDPI Publications
URI: http://hdl.handle.net/10027/20639
ISSN: 1422-0067
Sponsor: The authors gratefully acknowledge financial support by the Ovarian Cancer Research Foundation Liz Tilberis Scholar Award and National Cancer Institute (Grant # CA160917; both to MVB).
Date Available in INDIGO: 2016-05-16
 

This item appears in the following Collection(s)

Show simple item record

Statistics

Country Code Views
United States of America 83
China 60
Russian Federation 23
Germany 9
Ukraine 4

Browse

My Account

Information

Access Key